{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-007019","form_type":"8-K/A","ticker":"BRGX","cik":"0001593184","company_name":"BIOREGENX, INC.","filed_at":"2024-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.909329+00:00","generated_at":"2026-05-30T17:19:47.003630+00:00","sec_items":["2.01","3.02","5.01","5.02","5.03","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioRegenx completes reverse merger; posts $3.6M net loss in 2023 with going concern doubt","bullets":["Merger effective March 8, 2024: BioRegenx merged into Findit; registrant renamed BioRegenx, Inc.","Exchanged 851.98M shares and 3,800 Series A preferred for 90% voting control; retired prior preferred and 172.2M common shares.","Audited 2023 results: net loss $3.6M, sales $3.41M, stockholders' deficit $2.07M; auditor flags going concern.","New leadership: William Resides CEO/Interim CFO; new board of 7 directors appointed (8 total including Thomas Powers).","Authorized common increased to 1.5B shares; Series A preferred voting rights corrected to 2,500 votes per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-007019","json":"https://secwatch.observer/filing/0001683168-24-007019.json","markdown":"https://secwatch.observer/filing/0001683168-24-007019.md","text":"https://secwatch.observer/filing/0001683168-24-007019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/bioregenx_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T17:19:47.003630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05f90f90ef","claim":"Gary Hennerberg was appointed as Director at BIOREGENX, INC..","evidence_excerpt":"the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]},{"claim_id":"06832cf40d","claim":"Gary Hennerberg was appointed as Secretary at BIOREGENX, INC..","evidence_excerpt":"Gary Hennerberg – Secretary","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Secretary"}]},{"claim_id":"0bc6bd686b","claim":"Jody Walker was appointed as Director at BIOREGENX, INC..","evidence_excerpt":"the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]},{"claim_id":"1962babfdd","claim":"Robert Doran was appointed as Executive Vice President at BIOREGENX, INC..","evidence_excerpt":"Robert Doran – Executive Vice President","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President"}]},{"claim_id":"2668385a95","claim":"Sherri Adams was appointed as Director at BIOREGENX, INC..","evidence_excerpt":"the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]},{"claim_id":"33c1f60f25","claim":"Sherri Adams was appointed as Chief Operating Officer at BIOREGENX, INC..","evidence_excerpt":"Sherri Adams – Chief Operating Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}]},{"claim_id":"56847f6bcc","claim":"Robert Doran was appointed as Director at BIOREGENX, INC..","evidence_excerpt":"the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]},{"claim_id":"7eea973ed4","claim":"Thomas Powers resigned as other_named_officer at BIOREGENX, INC..","evidence_excerpt":"Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}]},{"claim_id":"89c33d2af0","claim":"William Resides was appointed as Interim Financial Officer at BIOREGENX, INC..","evidence_excerpt":"William Resides – Chief Executive Officer, Interim Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Financial Officer"}]},{"claim_id":"9d36766ec2","claim":"Suzanne Bird was appointed as Director at BIOREGENX, INC..","evidence_excerpt":"the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]},{"claim_id":"b2e93fb3e5","claim":"Raymond Firth resigned as other_named_officer at BIOREGENX, INC..","evidence_excerpt":"Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}]},{"claim_id":"ca8606dd52","claim":"William Resides was appointed as Director at BIOREGENX, INC..","evidence_excerpt":"the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]},{"claim_id":"d9ff17addb","claim":"William Resides was appointed as Chief Executive Officer at BIOREGENX, INC..","evidence_excerpt":"William Resides – Chief Executive Officer, Interim Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}]},{"claim_id":"db5ce52d40","claim":"Raymond Firth resigned as director at BIOREGENX, INC..","evidence_excerpt":"Effective March 8, 2024, Raymond Firth resigned as a director of the Registrant","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}]},{"claim_id":"f9c1a6cba8","claim":"Gary Kiss was appointed as Director at BIOREGENX, INC..","evidence_excerpt":"the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}